Vanguard Health Care Fund... (VGHAX)
NASDAQ: VGHAX
· Real-Time Price · USD
77.77
1.90 (2.50%)
At close: Apr 21, 2025, 9:30 AM
2.50% (1D)
Bid | - |
Market Cap | 35.43B |
AUM | 35.4B |
NAV | 75.87 |
EPS (ttm) | 4.25 |
PE Ratio (ttm) | 18.31 |
Shares Out | 455.61M |
Inception Date | Nov 12, 2001 |
Ask | - |
Volume | 0 |
Open | 77.77 |
Previous Close | 75.87 |
Day's Range | 77.77 - 77.77 |
52-Week Range | 69.01 - 96.45 |
Holdings | 85 |
Expense Ratio | 0.32% |
About VGHAX
For more than 25 years, this actively managed fund has offered investors low-cost exposure to domestic and foreign companies involved in various aspects of the health care industry, such as pharmaceutical firms, medical supply companies, and research firms. The fund tends to be more geographically diverse and exhibit lower turnover than other health care funds. Still, one risk to note is the fund’s narrow scope, investing solely within the health care sector. Returns may vary widely from year to year, so this fund should be considered complementary to a diversified portfolio with a long-term time horizon.
Asset Class Health
Ticker Symbol VGHAX
Inception Date Nov 12, 2001
Provider Vanguard
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 36.85% of assets
Name | Symbol | Weight |
---|---|---|
Eli Lilly And Compan... | LLY | 10.37% |
Merck & Co., Inc. | MRK | 4.35% |
Boston Scientific Co... | BSX | 4.18% |
Vertex Pharmaceutica... | VRTX | 3.51% |
Intuitive Surgical, ... | ISRG | 2.69% |
Danaher Corporation | DHR | 2.66% |
Abbott Laboratories | ABT | 2.46% |
Edwards Lifesciences... | EW | 2.43% |
Bristol-myers Squibb... | BMY | 2.22% |
Johnson & Johnson | JNJ | 1.98% |
Dividends Dividend Yield 11.74%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Mar 28, 2025 | $1.4804 | Mar 31, 2025 |
Dec 20, 2024 | $7.4764 | Dec 23, 2024 |
Mar 27, 2024 | $2.6083 | Mar 28, 2024 |
Dec 27, 2023 | $3.5137 | Dec 28, 2023 |
Mar 28, 2023 | $2.8502 | Mar 29, 2023 |